https://www.selleckchem.com/pr....oducts/ac-fltd-cmk.h
To reduce waitlist mortality, living donor liver transplantation (LDLT) has increased over the past decade in US, however, not at a rate sufficient to completely mitigate organ shortage. As a result, there are ongoing efforts to expand the living liver donor pool. Simultaneously, the prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in the general population has increased, which has significant implications on the pool of potential living liver donors. As such, a clinical assessment algorithm that exhaustively evaluates for NA
Beğen
Yorum Yap
Paylaş
